The overarching question we want investigated is whether identifiable neuromyofascial findings represent an additional, potentially modifiable contributor to symptom burden and functional limitation in some patients, and whether that contribution can be measured independently.

The initial research agenda is organized around six questions.

1. Can different examiners identify the same findings?

Clear definitions and a standardized assessment procedure are needed. When two appropriately trained examiners assess the same patient independently, do they identify the same locations, restrictions, and functional findings? The method must become explicit enough that another clinician can investigate it without relying on Dr. Lamb’s personal interpretation.

2. What do the examination findings correspond to objectively?

Whether palpation-based impressions correlate with measurable differences in tissue properties, movement, strength, neurological function, or imaging. Measurement approaches should be selected with relevant specialists. A palpable restriction does not establish fibrosis, nerve compression, or tethering. Those are interpretations requiring separate investigation.

3. How common and specific are these findings?

Within one clearly defined patient population, how frequently do the proposed findings occur, and how do they compare with appropriately selected controls? The question is whether the findings distinguish clinically meaningful subgroups rather than reflecting abnormalities also common in people without the same symptoms.

4. Which patients are more likely to benefit, not benefit, or experience harm?

Prospective patient selection criteria are needed. Do particular combinations of injury history, examination findings, or functional impairment predict outcomes? Research must account for nonresponders and adverse outcomes, not only patients with striking improvements.

5. Are changes clinically meaningful, durable, and acceptably safe?

Prespecified outcomes, consistent follow-up, and complete reporting of adverse events, concurrent care, and additional treatment. Immediate changes are worth documenting, but the more important questions concern sustained function, quality of life, recurrence, and the amount of ongoing care required. The effects of an initial intervention should be distinguished from those of subsequent rehabilitation or maintenance treatment.

6. What explains any observed changes?

Where improvements occur, competing explanations need investigation rather than assuming the proposed mechanism has been demonstrated. The working hypothesis concerns a possible additional contributor to symptoms and disability. It should not be presented as replacing established diagnoses or demonstrating modification of an underlying disease process.

The proposed sequence begins with reproducibility, measurement, and a selected lead population, then builds toward prospective outcome studies.